IL96088A - N-substituted derivatives of 3r, 4r-ethyl-[(1-methyl-1h-imidazol-5-yl)methyl]-2-pyrrolidinone, their preparation and pharmaceutical compositions containing them - Google Patents

N-substituted derivatives of 3r, 4r-ethyl-[(1-methyl-1h-imidazol-5-yl)methyl]-2-pyrrolidinone, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL96088A
IL96088A IL9608890A IL9608890A IL96088A IL 96088 A IL96088 A IL 96088A IL 9608890 A IL9608890 A IL 9608890A IL 9608890 A IL9608890 A IL 9608890A IL 96088 A IL96088 A IL 96088A
Authority
IL
Israel
Prior art keywords
methyl
imidazol
ethyl
pyrrolidinone
nmr
Prior art date
Application number
IL9608890A
Other languages
English (en)
Other versions
IL96088A0 (en
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of IL96088A0 publication Critical patent/IL96088A0/xx
Publication of IL96088A publication Critical patent/IL96088A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9608890A 1989-11-13 1990-10-23 N-substituted derivatives of 3r, 4r-ethyl-[(1-methyl-1h-imidazol-5-yl)methyl]-2-pyrrolidinone, their preparation and pharmaceutical compositions containing them IL96088A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/434,929 US5264449A (en) 1989-11-13 1989-11-13 N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidinone

Publications (2)

Publication Number Publication Date
IL96088A0 IL96088A0 (en) 1991-07-18
IL96088A true IL96088A (en) 1995-03-30

Family

ID=23726283

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9608890A IL96088A (en) 1989-11-13 1990-10-23 N-substituted derivatives of 3r, 4r-ethyl-[(1-methyl-1h-imidazol-5-yl)methyl]-2-pyrrolidinone, their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US5264449A (no)
EP (1) EP0429232A1 (no)
JP (1) JPH03188075A (no)
CN (1) CN1026589C (no)
AU (1) AU631025B2 (no)
CA (1) CA2027604A1 (no)
FI (1) FI905589A0 (no)
HU (1) HU207512B (no)
IE (1) IE904067A1 (no)
IL (1) IL96088A (no)
NO (1) NO177056C (no)
NZ (1) NZ235735A (no)
PT (1) PT95874A (no)
RU (1) RU2015978C1 (no)
ZA (1) ZA908386B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453434A (en) * 1989-11-13 1995-09-26 Allergan, Inc. N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidone
SG44510A1 (en) * 1991-12-18 1997-12-19 Schering Corp Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US5677327A (en) * 1995-06-22 1997-10-14 Allergan Method for identifying muscarinic agents lacking miotic side effects
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2250353A1 (en) * 1996-04-03 1997-10-09 Christopher J. Dinsmore Inhibitors of farnesyl-protein transferase
EP0891352A4 (en) * 1996-04-03 2001-08-16 Merck & Co Inc INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
US5675038A (en) * 1996-07-18 1997-10-07 Allergan Lithium and amine dissolving metal reduction
US5675019A (en) * 1996-07-18 1997-10-07 Allergan Process for making piloloctam and derivatives thereof
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
WO2003057131A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-[2-[ 4-[[[[(4-methyl cyclohexyl) amino]carbonyl] amino]sulfonyl] phenyl]ethyl] -2-oxo-1h-pyrrole -1-carboxamide
CN104211638A (zh) * 2014-08-13 2014-12-17 李增 一种脂肪氨基取代的芸香碱类衍生物及其制备和作为抗阿尔兹海默症的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470197A (en) * 1967-08-30 1969-09-30 Miles Lab 1-substituted derivatives of 3-ethyl-4 - (1-methylimidazolyl-(5)-methyl)-2-pyrrolidinone
US5055467A (en) * 1989-11-13 1991-10-08 Allergan, Inc. Pharmaceutical epinephrine-pilocarpine compounds

Also Published As

Publication number Publication date
NZ235735A (en) 1992-03-26
NO904901L (no) 1991-05-14
US5264449A (en) 1993-11-23
HU207512B (en) 1993-04-28
CN1051730A (zh) 1991-05-29
CA2027604A1 (en) 1991-05-14
FI905589A0 (fi) 1990-11-12
EP0429232A1 (en) 1991-05-29
NO177056C (no) 1995-07-12
IE904067A1 (en) 1991-05-22
AU631025B2 (en) 1992-11-12
PT95874A (pt) 1991-09-13
JPH03188075A (ja) 1991-08-16
CN1026589C (zh) 1994-11-16
HUT56360A (en) 1991-08-28
RU2015978C1 (ru) 1994-07-15
HU907116D0 (en) 1991-05-28
AU6652890A (en) 1991-05-16
NO177056B (no) 1995-04-03
IL96088A0 (en) 1991-07-18
ZA908386B (en) 1991-08-28
NO904901D0 (no) 1990-11-12

Similar Documents

Publication Publication Date Title
IL96088A (en) N-substituted derivatives of 3r, 4r-ethyl-[(1-methyl-1h-imidazol-5-yl)methyl]-2-pyrrolidinone, their preparation and pharmaceutical compositions containing them
US5453434A (en) N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidone
EP0869794B1 (en) Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
JP2021046439A (ja) 併用療法
CA2511255C (en) 2-piperidone derivatives as prostaglandin agonists
US20040044045A1 (en) Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6353000B1 (en) 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
WO2002089813A2 (en) 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
AU2002305416A1 (en) 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
US5807892A (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US6649653B1 (en) 15-fluoro prostaglandins as ocular hypotensives
US5866602A (en) Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
EP0585380B1 (en) Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
US6531614B2 (en) Method of prostaglandin synthesis
US5055467A (en) Pharmaceutical epinephrine-pilocarpine compounds
EP1185524B1 (en) 3-heteroarylalkyl substituted gaba analogs
US4312882A (en) Thienyoxy and furyl containing analogs of prostacyclin and their use as medicaments
US4304783A (en) Thienyl, thienyloxy or furyl substituted prostaglandin derivatives in the 6-keto-PGE1 series
CA2528010C (en) 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure
US5198545A (en) Pharmaceutical epinephrine-pilocarpine compounds and process of preparation thereof
US20020198382A1 (en) Oxiran carboxylic acids for the treatment of diabetes
EP0329169A1 (en) N-(lower alkyl)-2-(3'-ureidobenzyl)-pyrrolidines
CA2528179A1 (en) Piperidinyl prostaglandin e analogs
US20040248854A1 (en) Piperidinyl prostaglandin E analogs
WO2004108669A1 (en) 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents

Legal Events

Date Code Title Description
RH Patent void